Metabolism of hCG and hLH to multiple urinary forms

被引:39
作者
Birken, S
Kovalevskaya, G
OConnor, J
机构
关键词
human chorionic gonadotropin; human luteinizing hormone; multiple urinary forms;
D O I
10.1016/S0303-7207(96)03942-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human chorionic gonadotropin (hCG) is synthesized primarily in the placenta while human luteinizing hormone (hLH) is produced in the pituitary. Both hormones are highly homologuous in structure and both appear to be altered to analogous molecular forms as the hormones are proteolytically processed, or metabolized, from tissue of origin, through the circulation, and finally to the urine. Placental hCG is excreted into urine as heterodimeric hormone, heterodimeric nicked hCG, free subunits (some nicked), and predominantly as the hCG beta core fragment. A pituitary form of heterodimeric hCG, which is partly sulfated as is pituitary hLH, was recently isolated and is likely the form of hCG observed in the urine of healthy postmenopausal women and nonpregnant premenopausal women as well. A pituitary form of the hLH beta core fragment, highly analogous in structure to that of urinary hCG beta core fragment, has been used to develop specific monoclonal antibody assays to measure urinary hLH beta core fragment which is excreted at significantly higher molar concentrations than is hLH in the urine of ovulating women 1 or 2 days after the LH surge. This fragment of LH appears in the urine of postmenopausal women as well. The development of the capability to distinguish the hCG beta core fragment from the hLH beta core fragment in urine may have useful applications in tumor marker assays, pregnancy tests, and menopause. While hCG urinary assays have been widely employed, urinary assays for hCG and hLH metabolites are much less used since the urinary molecular forms are only partly known. Our studies of hCG and hLH urinary metabolites are directed towards improvement of the utility of urinary measurements of molecules derived from these hormones. Since many of the molecular forms of these two hormones in urine differ from their forms in blood, it may be necessary to produce new immunoassays as well as novel urinary reference preparations to accurately measure these molecules within their urinary matrix. Copyright (C) 1996 Elsevier Science Ireland Ltd.
引用
收藏
页码:121 / 131
页数:11
相关论文
共 85 条
[71]  
PETTERSSON K, 1991, CLIN CHEM, V37, P1745
[72]   OCCURRENCE OF FRAGMENTATION OF FREE AND COMBINED FORMS OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN [J].
PUISIEUX, A ;
BELLET, D ;
TROALEN, F ;
RAZAFINDRATSITA, A ;
LHOMME, C ;
BOHUON, C ;
BIDART, JM .
ENDOCRINOLOGY, 1990, 126 (02) :687-694
[73]   PREVALENCE OF AN IMMUNOLOGICAL LH BETA-SUBUNIT VARIANT IN A UK POPULATION OF HEALTHY WOMEN AND WOMEN WITH POLYCYSTIC-OVARY-SYNDROME [J].
RAJKHOWA, M ;
TALBOT, JA ;
JONES, PW ;
PETTERSSON, K ;
HAAVISTO, AM ;
HUHTANIEMI, I ;
CLAYTON, RN .
CLINICAL ENDOCRINOLOGY, 1995, 43 (03) :297-303
[74]  
SMITH PL, 1993, J BIOL CHEM, V268, P795
[75]  
SMITH PL, 1990, J BIOL CHEM, V265, P874
[77]   ASPARAGINE-LINKED OLIGOSACCHARIDE STRUCTURES DETERMINE CLEARANCE AND ORGAN DISTRIBUTION OF PITUITARY AND RECOMBINANT THYROTROPIN [J].
SZKUDLINSKI, MW ;
THOTAKURA, NR ;
TROPEA, JE ;
GROSSMANN, M ;
WEINTRAUB, BD .
ENDOCRINOLOGY, 1995, 136 (08) :3325-3330
[78]   SULFATE AND PHOSPHATE ANALYSIS IN GLYCOPROTEINS AND OTHER BIOLOGIC COMPOUNDS USING ION CHROMATOGRAPHY - APPLICATION TO GLYCOPROTEIN HORMONES AND SUGAR ESTERS [J].
WARD, DN ;
WEN, T ;
BOUSFIELD, GR .
JOURNAL OF CHROMATOGRAPHY, 1987, 398 :255-264
[79]   METABOLIC-CLEARANCE RATE AND URINARY CLEARANCE OF PURIFIED BETA-CORE [J].
WEHMANN, RE ;
BLITHE, DL ;
FLACK, MR ;
NISULA, BC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03) :510-517
[80]   METABOLIC AND RENAL CLEARANCE RATES OF PURIFIED HUMAN CHORIONIC-GONADOTROPIN [J].
WEHMANN, RE ;
NISULA, BC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (01) :184-194